Dermatology Review
facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
5/2024
vol. 111
 
Share:
Send email
Share:
abstract:
Special paper

Basal Cell Carcinoma: Diagnostic and Therapeutic Management – Expert Opinion of the Polish Dermatological Society

Aleksandra Lesiak
1, 2
,
Jacek Szepietowski
3
,
Joanna Czuwara
4
,
Grażyna Kamińska-Winciorek
5
,
Joanna Narbutt
1
,
Adam Reich
6
,
Dorota Kiprian
7
,
Joanna Maj
3
,
Witold Owczarek
8
,
Agnieszka Owczarczyk-Saczonek
9
,
Lidia Rudnicka
4
,
Irena Walecka
10
,
Aleksandra Dańczak-Pazdrowska
11
,
Maciej Pastuszczak
12
,
Agnieszka Żebrowska
13
,
Piotr Rutkowski
14
,
Michał Sobjanek
15
,
Martyna Sławińska
15
,
Małgorzata Sokołowska-Wojdyło
15
,
Barbara Zegarska
16
,
Wojciech Zegarski
17
,
Magdalena Ciażyńska
1, 18

  1. Department of Dermatology, Pediatric and Oncologic Dermatology, Medical University of Lodz, Poland
  2. Laboratory of Autoinflammatory, Genetic and Rare Skin Disorders, Medical University of Lodz, Poland
  3. Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Poland
  4. Department of Dermatology, Medical University of Warsaw, Poland
  5. Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sk³odowska-Curie Memorial Cancer Centre and Institute of Oncology, Branch in Gliwice, Poland
  6. Department of Dermatology, Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Poland
  7. Radiotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  8. Department of Dermatology, Military Institute of Medicine, Warsaw, Poland
  9. Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury, Olsztyn, Poland
  10. Department of Dermatology, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland
  11. Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland
  12. Department of Dermatology in Zabrze, Silesian Medical University in Katowice, Poland
  13. Department of Dermatology and Venereology, Medical University of Lodz, Poland
  14. Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sk³odowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland
  15. Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Poland
  16. Department of Cosmetology and Aesthetic Dermatology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland
  17. Department of Oncological Surgery, Oncology Centre, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland
  18. Sub-Department of Chemotherapy and Department of One-Day Chemotherapy, NU-MED Specialized Oncology Hospital, Tomaszow Mazowiecki, Poland
Dermatol Rev/Przegl Dermatol 2024, 111, 319-333
DOI: https://doi.org/10.5114/dr.2024.149029
Online publish date: 2025/02/25
View full text Get citation
 
PlumX metrics:
The incidence of skin cancer continues to rise, presenting a significant epidemiological challenge for contemporary medicine. The most prevalent cancer in the Caucasian population is basal cell carcinoma. The gold standard for diagnosing skin cancers remains histopathological examination. However, for low-risk basal cell carcinoma subtypes, non-invasive imaging techniques may suffice to confirm the diagnosis, particularly prior to planned topical or destructive therapies. The guidelines below outline the clinical and pathomorphological subtypes of basal cell carcinoma, its dermoscopic characteristics, staging, and the available options for treatment and prevention of recurrence. The primary and preferred treatment method is the surgical removal of the lesion. The remaining non-surgical methods have lower cure rates and should therefore be reserved for cases with a low risk of recurrence, when surgery is contraindicated or not feasible.
keywords:

basal cell carcinoma, recommendations


Indeks osobowy
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.